We are live on ! Find out more
AQST icon

Aquestive Therapeutics
AQST

97 hedge funds and large institutions have $177M invested in Aquestive Therapeutics in 2024 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 9

267% more capital invested

Capital invested by funds: $48.1M → $177M (+$129M)

115% more call options, than puts

Call options by funds: $4.24M | Put options by funds: $1.97M

70% more funds holding

Funds holding: 57 → 97 (+40)

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

10.46% more ownership

Funds ownership: 35.66% → 46.12% (+10%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
97
Holders Change
+40
Holders Change %
+70.18%
% of All Funds
1.4%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
51
Increased
23
Reduced
14
Closed
9
Calls
$4.24M
Puts
$1.97M
Net Calls
+$2.27M
Net Calls Change
+$2.02M

Top Buyers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
+$18.5M
2
Franklin Resources
Franklin Resources
California
+$7.39M
3
LCM
Laurion Capital Management
New York
+$5.14M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.51M
5
MIM
Monashee Investment Management
Massachusetts
+$3.33M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$7.93M
2
EIM
Essex Investment Management
Massachusetts
-$776K
3
Marshall Wace
Marshall Wace
United Kingdom
-$584K
4
Two Sigma Investments
Two Sigma Investments
New York
-$374K
5
Corient Private Wealth
Corient Private Wealth
Florida
-$319K
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
26
Stifel Financial
Missouri
$1.66M +$1.3M +389,882 New
Janney Montgomery Scott
27
Janney Montgomery Scott
Pennsylvania
$1.46M +$1.14M +341,860 New
HF
28
HRT Financial
New York
$1.22M +$950K +285,360 New
Jane Street
29
Jane Street
New York
$1.12M +$356K +107,055 +69%
LCM
30
Legato Capital Management
California
$1.06M -$306K -92,061 -27%
LI
31
Latash Investments
Alaska
$1.04M – – –
Citadel Advisors
32
Citadel Advisors
Florida
$955K +$188K +56,456 +34%
Man Group
33
Man Group
United Kingdom
$946K +$739K +222,086 New
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$935K -$140K -42,193 -16%
BCM
35
Bridgeway Capital Management
Texas
$822K – – –
State Street
36
State Street
Massachusetts
$774K +$100K +30,100 +20%
EI
37
EAM Investors
California
$461K +$360K +108,244 New
VF
38
Virtu Financial
New York
$438K +$235K +70,666 +220%
JP Morgan Chase
39
JP Morgan Chase
New York
$436K +$171K +51,363 +101%
Northern Trust
40
Northern Trust
Illinois
$417K +$22.4K +6,728 +7%
Corient Private Wealth
41
Corient Private Wealth
Florida
$408K -$319K -95,813 -50%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$406K +$317K +95,213 New
Morgan Stanley
43
Morgan Stanley
New York
$396K +$148K +44,592 +92%
MTIM
44
Marathon Trading Investment Management
Pennsylvania
$383K +$300K +90,000 New
CWM
45
Cahill Wealth Management
Michigan
$367K +$287K +86,213 New
Osaic Holdings
46
Osaic Holdings
Arizona
$365K +$286K +85,780 New
DC
47
Diametric Capital
Massachusetts
$290K +$227K +68,088 New
SSA
48
Schonfeld Strategic Advisors
New York
$267K +$209K +62,747 New
BPA
49
Beacon Pointe Advisors
California
$256K – – –
EFMC
50
Empire Financial Management Company
New York
$256K +$200K +60,000 New
1
2
3 4 5

AQST Hedge Fund Activity: Q1 2024 in Review

97 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Aquestive Therapeutics (AQST) for Q1 2024, worth a combined $177M — up 267% from $48.1M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new AQST positions and 9 closed out — a net gain of 42 holders — while 23 added to existing stakes and 14 trimmed.

The largest buyer was VR Adviser, opening a new position worth an estimated $18.5M. The largest seller was Armistice Capital, exiting entirely with an estimated $7.93M sold.

  • 97 institutional investors held Aquestive Therapeutics (AQST) as of Q1 2024, up from 57 in Q4 2023.
  • Funds reported $177M of Aquestive Therapeutics stock for Q1 2024, up 267% quarter-over-quarter.
  • 51 funds opened new Aquestive Therapeutics positions in Q1 2024 and 9 closed out, a net change of +42 holders.
  • The largest Aquestive Therapeutics buyer in Q1 2024 was VR Adviser, an estimated $18.5M added.
  • The largest Aquestive Therapeutics seller in Q1 2024 was Armistice Capital, an estimated $7.93M sold.

Based on aggregated 13F filings for Q1 2024.